APA (7th ed.) Citation

S, F., A, P., CW, S., R, F., A, P., L, B., . . . M, D. (2016). Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: Final results of a European MCL Network Phase II Trial. Leukemia, 30(4), 984. https://doi.org/10.1038/leu.2015.215

Chicago Style (17th ed.) Citation

S, Ferrero, et al. "Radioimmunotherapy in Relapsed/refractory Mantle Cell Lymphoma Patients: Final Results of a European MCL Network Phase II Trial." Leukemia 30, no. 4 (2016): 984. https://doi.org/10.1038/leu.2015.215.

MLA (9th ed.) Citation

S, Ferrero, et al. "Radioimmunotherapy in Relapsed/refractory Mantle Cell Lymphoma Patients: Final Results of a European MCL Network Phase II Trial." Leukemia, vol. 30, no. 4, 2016, p. 984, https://doi.org/10.1038/leu.2015.215.